Yeni jenerasyon proteozom inhibitörleriyle olan çevresel nöropati yükünün fda yan etki raporlama sistemi kullanılarak pazarlama sonrası analizi

Translated title of the contribution: Post-marketing analysis of peripheral neuropathy burden with new-generation proteasome inhibitors using the fda adverse event reporting system

Syeda A. Mina, Ibrahim N. Muhsen, Ethan A. Burns, Humaira Sarfraz, Sai Ravi Pingali, Jiaqiong Xu, Shahrukh K. Hashmi

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Post-marketing analysis of peripheral neuropathy burden with new-generation proteasome inhibitors using the fda adverse event reporting system'. Together they form a unique fingerprint.

Medicine & Life Sciences